Dergiler / Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi / 2014 / Cilt: 27 - Sayı: 4

Nalmefene for Reduced-Risk Drinking: it is not Only Fancy Term For Harm Reduction

Sayfa
275–280
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

EVREN, C. (2014). Nalmefene for Reduced-Risk Drinking: it is not Only Fancy Term For Harm Reduction. Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi, Cilt: 27 - Sayı: 4, 275–280. https://ajindex.com/articles/203377

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. EMCDDA. Synthetic Perspectives on drugs. Cannabinoids in Europe. http://www.emcdda.europa.eu/attachements. cfm/att_212361_EN_EMCDDA_POD_2013_Synthetic%20 cannabinoids.pdf. Accessed March 19, 2014
  2. Winstock AR, Barratt MJ. Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug Alcohol Depend 2013; 131:106-111
  3. EMCDDA. Understanding the ‘Spice’ phenomenon. http:// www.emcdda.europa.eu/attachements.cfm/att_80086_EN_ Spice%20Thematic%20paper%20%E2%80%94%20final%20 version.pdf. Accessed March 19, 2014
  4. Lewin AH, Seltzman HH, Carroll FI, Mascarella SW, Reddy PA. Emergence and properties of spice and bath salts: A medicinal chemistry perspective. Life Sci 2014; 97:9-19
  5. Gurdal F, Asirdizer M, Aker RG, Korkut S, Gocer Y, Kucukibrahimoglu EE, Ince CH. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey. J Forensic Leg Med 2013; 20:667- 672
  6. Uchiyama N, Kikura-Hanajiri R, Ogata J, Goda Y. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci Int 2010; 198:31-38
  7. Zuba D, Byrska B, Maciow M. Comparison of “herbal highs” composition. Anal Bioanal Chem 2011; 400:119-126
  8. Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives [K2, spice], synthetic cathinones [bath salts], kratom, Salvia divinorum, methoxetamine, and piperazine. J Med Toxicol 2012; 8:15-32
  9. Ogata J, Uchiyama N, Kikura-Hanajiri R, Goda Y. DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs. Forensic Sci Int 2013; 227:33-41
  10. Glue P, Al-Shaqsi S, Hancock D, Gale C, Strong B, Schep L. Hospitalisation associated with use of the synthetic cannabinoid K2. N Z Med J 2013; 126:18-23
  11. Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med 2012; 60:435-438
  12. Centers for Disease Control and Prevention (CDC). Acute kidney injury associated with synthetic cannabinoid use— multiple states. MMWR Morb Mortal Wkly Rep 2013; 62:93-98
  13. Mir A, Obafemi A, Young A, Kane C. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics 2011;128:1622-1627
  14. UNODC. Synthetic cannabinoids in herbal p